Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
172M
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
54.7M
-
Shares change
-
-1.34M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
-$13M
-
Put/Call ratio
-
0.76
-
Number of buys
-
99
-
Number of sells
-
-59
-
Price
-
$20.74
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q2 2025
206 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share as of Q2 2025.
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
of 172M outstanding shares and own 31.84% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.88M shares), Deep Track Capital, LP (5.13M shares), FMR LLC (4.91M shares), JANUS HENDERSON GROUP PLC (4.57M shares), BAKER BROS. ADVISORS LP (2.51M shares), BVF INC/IL (1.77M shares), Capital International Investors (1.62M shares), AMERIPRISE FINANCIAL INC (1.59M shares), RA CAPITAL MANAGEMENT, L.P. (1.52M shares), and CITADEL ADVISORS LLC (1.33M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.